Janney Initiates CareDx With Buy Rating, $12 Target

By: via Benzinga
Janney Montgomery Scott’s Paul Knight has initiated coverage of CareDx Inc (NASDAQ: CDNA) with a Buy rating and fair value ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.